Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1995
11/22/1995EP0682700A1 Use of intra-platelet urokinase-type plasminogen activators for long-term inhibition of thrombosis
11/22/1995EP0682529A1 Antibody for the treatment of insulin dependent diabetes
11/22/1995EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS
11/22/1995EP0682525A1 Methods for treating amyotrophic lateral sclerosis with cntf
11/22/1995EP0682524A1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
11/22/1995EP0635028A4 Pulmonary surfactant protein fragments.
11/22/1995EP0427788B1 Methods for isolating herpes virus thymidine kinase-encoding dna
11/22/1995CN1112368A Paper strengthened with solubilized collagen, and method for making the same
11/22/1995CN1112127A A novel polypeptide of protein p140 and DNAS encoding it
11/22/1995CN1112125A Acyloxyhexanoic acid derivatives
11/22/1995CN1112117A Imidazole-containing inhibitors of farnesyl protein transferase
11/22/1995CN1112020A A cardiotropic formulation
11/22/1995CN1112019A Novel process for the preparation of cetrorelix lyophilisate
11/21/1995US5468847 Method of isolating and purifying a biomacromolecule
11/21/1995US5468845 Antibodies to osteogenic proteins
11/21/1995US5468777 Method and agents for preventing and reversing the staining of teeth
11/21/1995US5468755 Therapeutic process for the treatment of the pathologies of Type II diabetes
11/21/1995US5468745 For administering to patients suffering from hypertension or congestive heart failure
11/21/1995US5468733 For treating cancer
11/21/1995US5468732 Phosphorus containing renin inhibitors
11/21/1995US5468731 Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
11/21/1995US5468730 Methods for the treatment of non-IgE-mediated diseases
11/21/1995US5468729 Method for treatment of autoimmune hepatitis
11/21/1995US5468728 Administering peptide exhibiting motilin activity, a peptide lyric enzyme inhibitor and surfactant
11/21/1995US5468727 Methods of normalizing metabolic parameters in diabetics
11/21/1995US5468726 Growth hormone releasing factor for neuropsychiatric disorders
11/21/1995US5468639 With specified amino acid sequence and plasmid comprising the same; vaccine against enteric infections
11/21/1995US5468634 Axl oncogene
11/21/1995US5468624 Polynucleotide with sequyence code and cells
11/21/1995US5468612 Proteins, genetic vectors and cells
11/21/1995US5468505 Local delivery of fibrinolysis enhancing agents
11/21/1995US5468494 Polypeptides as anticarcinogenic agents
11/21/1995US5468483 Bacillus thuringiensis anti-giardia treatment
11/21/1995US5468480 Pharmaceutical composition of purified chymopapain
11/21/1995US5468479 Compositions containing lactic acid bacterium Streptococcus salivarius
11/21/1995US5468478 Conjugates of superoxide dismutage coupled to high molecular weight polyalkylene glycols
11/21/1995US5468468 Method for making a monoclonal antibody, monoclonal antibodies to α PD
11/21/1995CA2149703A1 Mucosal administration of pneumococcal antigens
11/21/1995CA1337604C Phospholipid complexes of extract of vitis vinifera, their preparation process and pharmaceutical and cosmetic compositions containing them
11/21/1995CA1337591C Therapeutic composition comprising oestrogen and antioestrogen
11/18/1995CA2148724A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica
11/16/1995WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME
11/16/1995WO1995030775A1 High-affinity ligands of insulin receptor antibodies, tachykinin substance p, hiv integrase and hiv-1 reverse transcriptase
11/16/1995WO1995030763A2 Retroviral vectors having a reduced recombination rate
11/16/1995WO1995030762A1 Sv-40 derived dna constructs comprising exogenous dna sequences
11/16/1995WO1995030761A2 Methods of in vivo gene delivery
11/16/1995WO1995030760A1 Use of prolactin for preventing and/or treating bird broodiness
11/16/1995WO1995030758A1 Recombinant hk2 polypeptide
11/16/1995WO1995030754A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof
11/16/1995WO1995030751A1 Lanthionine-containing antimicrobial compound
11/16/1995WO1995030750A2 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
11/16/1995WO1995030694A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties
11/16/1995WO1995030693A1 Neurogenic differentiation (neurod) genes and proteins
11/16/1995WO1995030692A1 Anti-fungal cyclic depsipeptides
11/16/1995WO1995030691A1 New peptide active substance and production thereof
11/16/1995WO1995030690A1 Novel tetrapeptides, their manufacture and use
11/16/1995WO1995030687A1 Neurokinine (tachykinine) antagonists
11/16/1995WO1995030686A1 Production of biologically active recombinant neurotrophic protein
11/16/1995WO1995030439A2 Prevention of tumor metastasis
11/16/1995WO1995030438A2 Methods and compositions to enhance endogenous fibrinolytic activity
11/16/1995WO1995030436A1 An adjuvant
11/16/1995WO1995030435A2 Compositions and treatment for multiple sclerosis
11/16/1995WO1995030434A1 Methods based on the role of neurotrophin 3 in female reproduction
11/16/1995WO1995030433A1 A novel brain endothelial cell protein and methods for its use
11/16/1995WO1995030432A1 Use of chondroitin sulphate proteoglycans for protection of neurons
11/16/1995WO1995030431A1 Method for reduction of headache pain
11/16/1995WO1995030430A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
11/16/1995WO1995030429A1 Novel ophthalmologic uses of protein c
11/16/1995WO1995030428A1 Human dnase
11/16/1995WO1995030418A1 Method of slowing the progression of hiv infection
11/16/1995WO1995030417A1 Potentiated antibiotic composition
11/16/1995WO1995030415A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/16/1995WO1995030412A1 Cytokine potentiator and remedy for diseases wherein cytokine activity is reduced
11/16/1995WO1995030339A1 Cloning, expression, and uses of human lactoferrin
11/16/1995WO1995028418A3 Tachykinin antagonists
11/16/1995WO1995025118A3 Inhibitors of sh2 domain interactions
11/16/1995WO1995019371A3 Expression of surface layer proteins
11/16/1995DE4415344A1 Aurantimycin B peptide antibiotic
11/16/1995DE19517773A1 Rekombinante PRRSV-Proteine, Diagnostik-Kits und solche rekombinanten PRRSV-Proteine enthaltenden Vakzinen Recombinant PRRSV proteins, diagnostic kits and such recombinant PRRSV proteins containing vaccines
11/16/1995CA2312047A1 Method for reduction of headache pain
11/16/1995CA2190027A1 A novel brain endothelial cell protein and methods for its use
11/16/1995CA2189990A1 Compositions and treatment for multiple sclerosis
11/16/1995CA2189774A1 Recombinant hk2 polypeptide
11/16/1995CA2189764A1 Neurokinine (tachykinine) antagonists
11/16/1995CA2189582A1 Sv-40 derived dna constructs comprising exogenous dna sequences
11/16/1995CA2189452A1 Methods of in vivo gene delivery
11/16/1995CA2189445A1 Use of prolactin for preventing and/or treating bird broodiness
11/16/1995CA2189432A1 An adjuvant
11/16/1995CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same
11/16/1995CA2189336A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/16/1995CA2189129A1 Anti-fungal cyclic depsipeptides
11/16/1995CA2188670A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties
11/16/1995CA2188450A1 Neurogenic differentiation (neurod) genes and proteins
11/16/1995CA2186621A1 Lanthionine-containing antimicrobial compound
11/16/1995CA2158977A1 Retroviral vectors having a reduced recombination rate
11/15/1995EP0682114A2 Expression of recombinant MPF-4, CPF-4, PF-4 and precursor compounds
11/15/1995EP0682113A2 Polypeptide produced in an endothelial cell line and DNA encoding it
11/15/1995EP0682112A1 Method for archiving expression, or to improve the level of expression of a gene
11/15/1995EP0682111A1 Chimeric or transgenic animal and process for screening pharmaceutical products
11/15/1995EP0682110A1 Recombinant DNA encoding PDGF A-chain polypeptides
1 ... 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 ... 3163